When offering a life insurance policy with a chronic illness accelerated death benefit rider in California, the agent must disclose how the rider differs from:

Why A is correct

California law (CIC §10295 et seq. and §10234.93) requires agents who offer accelerated death benefit riders for chronic illness to disclose to the consumer how the rider differs from a standalone long-term care insurance policy. The accelerated benefit is paid as an advance against the life insurance death benefit, while LTC insurance is a separate policy providing care benefits without reducing a life insurance face amount. The disclosure ensures consumers understand that the rider is not a substitute for long-term care insurance and may not cover all long-term care needs.

Why the other options are wrong

• The required disclosure compares the rider to long-term care insurance; disability income insurance is a different product not covered by this specific comparison rule. This answer describes a different situation from the one in the question and is therefore incorrect under the facts given here.
• Medicare supplement, or Medigap, policies fill gaps in Medicare; the statutory disclosure specifically addresses the ADB-versus-LTC difference. This choice does not fit the arrangement described in the question, so it is clearly not the right option to choose.
• Annuities are retirement income products and are not the subject of the chronic illness accelerated death benefit disclosure requirement. Accordingly, this option is not correct because it does not match the specific rule or product that is described in the question.

Memory hook

California requires disclosing that a chronic-illness ADB rider is not an LTC policy.

Why A is correct

California requires that when an accelerated death benefit for chronic illness is marketed in connection with long-term care needs, the applicant must receive a disclosure of the significant differences between the accelerated death benefit and a long-term care insurance policy. The products differ in how benefits are triggered, how they are structured, and how they are regulated, and a buyer could be harmed by assuming they are interchangeable. The disclosure duty is specifically designed to prevent that confusion. The disclosure must be made before the application is completed so the buyer's decision is informed.

Why the other options are wrong

• B) The two products have different triggering conditions, benefit structures, and regulatory frameworks; they cannot be treated as identical. The disclosure must be given before the application is completed so the buyer can make an informed decision.
• C) The disclosure rule does not create a free long-term care benefit; no coverage is added at no cost. The two products trigger benefits differently and are regulated under different statutory frameworks.
• D) Marketing is permitted; the obligation is to disclose the differences, not to stop selling the life policy. No statute adds long-term care coverage to a life policy without a premium for that benefit.

Memory hook

ADB for chronic illness is not LTC. California says disclose the gap or do not sell the confusion.